Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | ACLY | P53396 | 1/20 | 0.36 |
| ▸ | ACACA | Q13085 | 1/20 | 0.36 |
| ▸ | CD81 | P60033 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.31 |
| ▸ | FDPS | P14324 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4929626 | 1.00 | ALOX15 (0.41) | ALOX15ALDH1A1ACLYACACACD81 | |
| SCHEMBL16318552 | 0.89 | EP300 (0.36) | ALOX15ACLYACACACD81 | |
| SCHEMBL16318487 | 0.87 | EP300 (0.39) | ALOX15ACLYACACACD81 | |
| SCHEMBL7631885 | 0.86 | ALOX15 (0.43) | ALOX15ALDH1A1ACLYACACACD81 | |
| SCHEMBL7631877 | 0.86 | ALOX15 (0.43) | ALOX15ALDH1A1ACLYACACACD81 | |
| SCHEMBL13604750 | 0.86 | ALOX15 (0.42) | ALOX15ALDH1A1USP2ATMTDP1 | |
| SCHEMBL25357868 | 0.85 | EP300 (0.42) | CD81 | |
| SCHEMBL25363650 | 0.85 | EP300 (0.42) | CD81 | |
| SCHEMBL25358305 | 0.85 | EP300 (0.42) | CD81 | |
| SCHEMBL23494193 | 0.84 | ALOX15 (0.41) | ALOX15ALDH1A1ACLYACACACD81 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240408180-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-12-12 | — | — | US | disclosed |
| WO-2022271537-A1 | COMPOSITIONS AND METHODS RELATING TO INJECTABLE MICROEMULSIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-12-29 | — | — | WO | disclosed |
| US-20220257767-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-08-18 | — | — | US | disclosed |
| EP-3946261-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | President And Fellows Of Harvard College (US) | 2022-02-09 | — | — | EP | disclosed |
| CN-113939273-A | Ionic liquids for drug delivery | 哈佛大学校长及研究员协会 | 2022-01-14 | — | — | CN | disclosed |
| WO-2020205409-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2020-10-08 | — | — | WO | disclosed |
| EP-0944654-B1 | ANIONIC POLYMERISATION OF ACRYLATES AND METHACRYLATES | BASF AG (DE) | 2002-03-20 | — | — | EP | disclosed |
| EP-0944654-A2 | ANIONIC POLYMERISATION OF ACRYLATES AND METHACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 1999-09-29 | — | — | EP | disclosed |
| WO-1998025975-A2 | ANIONIC POLYMERISATION OF ACRYLATES AND METHACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 1998-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220257767-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | SLCO4C1, SLC47A1, ABCB11 | ALOX15 3128/4885ALDH1A1 898/4885ACLY 3512/4885 |
| US-20240408180-A1 | IONIC LIQUIDS FOR DRUG DELIVERY | SLCO4C1, SLC47A1, ABCB11 | ALOX15 3128/4885ALDH1A1 898/4885ACLY 3512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.